BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8048435)

  • 1. Facility mortality rates for new end-stage renal disease patients: implications for quality improvement.
    McClellan W; Soucie JM
    Am J Kidney Dis; 1994 Aug; 24(2):280-9. PubMed ID: 8048435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable mortality rates among dialysis treatment centers.
    McClellan WM; Flanders WD; Gutman RA
    Ann Intern Med; 1992 Aug; 117(4):332-6. PubMed ID: 1637029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the care of patients treated with hemodialysis: a report from the Health Care Financing Administration's ESRD Core Indicators Project.
    McClellan WM; Soucie JM; Krisher J; Caruana R; Haley W; Farmer C
    Am J Kidney Dis; 1998 Apr; 31(4):584-92. PubMed ID: 9531173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis treatment center early mortality rates for incident hemodialysis patients are associated with the quality of care prior to starting but not following onset of dialysis.
    Kanda E; Erickson K; Bond TC; Krisher J; McClellan WM
    Am J Nephrol; 2011; 33(5):390-7. PubMed ID: 21464568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Dialysis Facility Referral for Kidney Transplantation Among Patients With End-Stage Renal Disease in Georgia.
    Patzer RE; Plantinga LC; Paul S; Gander J; Krisher J; Sauls L; Gibney EM; Mulloy L; Pastan SO
    JAMA; 2015 Aug; 314(6):582-94. PubMed ID: 26262796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional status and quality of life: predictors of early mortality among patients entering treatment for end stage renal disease.
    McClellan WM; Anson C; Birkeli K; Tuttle E
    J Clin Epidemiol; 1991; 44(1):83-9. PubMed ID: 1986062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study.
    Hasegawa T; Nakai S; Masakane I; Watanabe Y; Iseki K; Tsubakihara Y; Akizawa T
    Am J Kidney Dis; 2015 Jun; 65(6):899-904. PubMed ID: 25641063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database.
    Hutchison CA; Crowe AV; Stevens PE; Harrison DA; Lipkin GW
    Crit Care; 2007; 11(2):R50. PubMed ID: 17451605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facility size, race and ethnicity, and mortality for in-center hemodialysis.
    Yan G; Norris KC; Xin W; Ma JZ; Yu AJ; Greene T; Yu W; Cheung AK
    J Am Soc Nephrol; 2013 Dec; 24(12):2062-70. PubMed ID: 23970120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess mortality in small dialysis centers. The result of dialyzing high-risk patients.
    Flanigan M
    ASAIO J; 1995; 41(2):177-81. PubMed ID: 7640423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis.
    McClellan WM; Soucie JM; Flanders WD
    J Am Soc Nephrol; 1998 Oct; 9(10):1940-7. PubMed ID: 9773796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival differences among older dialysis patients in the southeast.
    Brogan D; Kutner NG; Flagg E
    Am J Kidney Dis; 1992 Oct; 20(4):376-86. PubMed ID: 1415207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodialysis adequacy in Network 5: disparity between states and the role of center effects.
    Fink JC; Armistead N; Turner M; Gardner J; Light P
    Am J Kidney Dis; 1999 Jan; 33(1):97-104. PubMed ID: 9915273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for hospital utilization in chronic dialysis patients. Southeastern Kidney Council (Network 6).
    Rocco MV; Soucie JM; Reboussin DM; McClellan WM
    J Am Soc Nephrol; 1996 Jun; 7(6):889-96. PubMed ID: 8793798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of hemodialysis patients: modeling differences in risk of dialysis centers.
    Sá Carvalho M; Henderson R; Shimakura S; Sousa IP
    Int J Qual Health Care; 2003 Jun; 15(3):189-96. PubMed ID: 12803346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
    Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
    Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-center correlation in dialysis adequacy.
    Fink JC; Gardner JF; Armistead NC; Turner MS; Light PD
    J Clin Epidemiol; 2000 Jan; 53(1):79-85. PubMed ID: 10693907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.